Form 4/A for PCSA Processa Pharmaceuticals, Inc.
Accepted 2026-05-19 17:17:20 ET · period of report 2026-04-30 · accession 0000897069-26-001154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-05-19 17:17 | 2026-04-30 | PCSA | Bigora Sian | Chief Development Off | P - Purchase | $2.71 | +1,971 | 7,481 | +36% | +$5,341 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-30 | P | A | 1,971 | $2.71 | 7,481 | D | — | — | (F1) Shares adjusted to correct immaterial errors. (F1) Shares adjusted to correct immaterial errors. (F1) Shares adjusted to correct immaterial errors. |